Osteopontin blockade attenuates renal injury after ischemia reperfusion by inhibiting NK cell infiltration

Shock

Volumn 47, Issue 1, 2017, Pages 52-60

  Cen, Cindy ^a   Aziz, Monowar ^a   Yang, Weng Lang ^a   Nicastro, Jeffrey M ^a   Coppa, Gene F ^a   Wang, Ping ^a  

^a FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

Author keywords

Acute kidney injury; Apoptosis; Inflammation; Neutrophils; NK cells

Indexed keywords

CASPASE 3; CREATININE; CXCL1 CHEMOKINE; GR1 PROTEIN; IMMUNOGLOBULIN G; INTERLEUKIN 6; KIDNEY INJURY MOLECULE 1; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; OSTEOPONTIN; PROTEIN; SODIUM CHLORIDE; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; ANTIBODY;

ADULT; ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; BLOOD; CELL POPULATION; CONFERENCE PAPER; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HISTOLOGY; IMMUNOHISTOCHEMISTRY; KIDNEY CELL; KIDNEY FUNCTION; KIDNEY INJURY; KIDNEY TISSUE; LYMPHOCYTIC INFILTRATION; MALE; MOUSE; NATURAL KILLER CELL; NEPHRITIS; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; NONHUMAN; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; REPERFUSION INJURY; TISSUE INJURY; TUNEL ASSAY; UPREGULATION; UREA NITROGEN BLOOD LEVEL; ACUTE KIDNEY FAILURE; ANIMAL; ANTAGONISTS AND INHIBITORS; C57BL MOUSE; DRUG EFFECTS; KIDNEY; METABOLISM; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION;

ACUTE KIDNEY INJURY; ANIMALS; ANTIBODIES; KIDNEY; KILLER CELLS, NATURAL; MALE; MICE; MICE, INBRED C57BL; NEUTROPHIL INFILTRATION; OSTEOPONTIN; REAL-TIME POLYMERASE CHAIN REACTION; REPERFUSION INJURY;

EID: 84981243993     PISSN: 10732322     EISSN: 15400514     Source Type: Journal    
DOI: 10.1097/SHK.0000000000000721     Document Type: Conference Paper

References (33)

1. Bonventre JV, Yang L: Cellular pathophysiology of ischemic acute kidney injury. J Clin Invest 121(11):4210-4221, 2011.
2. Coca SG, Yusuf B, Shlipak MG, Garg AX, Parikh CR: Long-term risk of mortality and other adverse outcomes after acute kidney injury: a systematic review and meta-analysis. Am J Kidney Dis 53(6):961-973, 2009.
3. Munshi R, Hsu C, Himmelfarb J: Advances in understanding ischemic acute kidney injury. BMC Med 9:11, 2011.
4. Tian H, Sun T, Hao D, Wang T, Li Z, Han S, Qi Z, Dong Z, Lv C, Wang X: The optimal timing of continuous renal replacement therapy for patients with sepsis-induced acute kidney injury. Int Urol Nephrol 46(10):2009-2014, 2014.
5. Lopes JA, Jorge S, Resina C, Santos C, Pereira A, Neves J, Antunes F, Prata MM: Acute kidney injury in patients with sepsis: a contemporary analysis. Int J Infect Dis 13(2):176-181, 2009.
6. Le Dorze M, Legrand M, Payen D, Ince C: The role of the microcirculation in acute kidney injury. Curr Opin Crit Care 15(6):503-508, 2009.
7. Akcay A, Nguyen Q, Edelstein CL: Mediators of inflammation in acute kidney injury. Mediators Inflamm 2009:137072, 2009.
8. Emlet DR, Shaw AD, Kellum JA: Sepsis-associated AKI: epithelial cell dysfunction. Semin Nephrol 35(1):85-95, 2015.
9. Zhang ZX, Wang S, Huang X, Min WP, Sun H, Liu W, Garcia B, Jevnikar AM: NK cells induce apoptosis in tubular epithelial cells and contribute to renal ischemia-reperfusion injury. J Immunol 181(11):7489-7498, 2008.
10. Zhang ZX, Shek K, Wang S, Huang X, Lau A, Yin Z, Sun H, Liu W, Garcia B, Rittling S, et al.: Osteopontin expressed in tubular epithelial cells regulates NK cell-mediated kidney ischemia reperfusion injury. J Immunol 185(2):967-973, 2010.
11. Victorino F, Sojka DK, Brodsky KS, McNamee EN, Masterson JC, Homann D, Yokoyama WM, Eltzschiq HK, Clambey ET: Tissue-resident NK cells mediate ischemic kidney injury and are not depleted by Anti-Asialo-GM1 antibody. J Immunol 195(10):4973-4985, 2015.
12. Vivier E, Tomasello E, Baratin M, Walzer T, Ugolini S: Functions of natural killer cells. Nat Immunol 9(5):503-510, 2008.
13. Xie Y, Sakatsume M, Nishi S, Narita I, Arakawa M, Gejyo F: Expression, roles, receptors, and regulation of osteopontin in the kidney. Kidney Int 60(5):1645-1657, 2001.
14. Noiri E, Dickman K, Miller F, Romanov G, Romanov VI, Shaw R, Chambers AF, Rittling SR, Denhardt DT, Goligorsky MS: Reduced tolerance to acute renal ischemia in mice with a targeted disruption of the osteopontin gene. Kidney Int 56(1):74-82, 1999.
15. Untergasser A, Cutcutache I, Koressaar T, Ye J, Faircloth BC, Remm M, Rozen SG: Primer3-new capabilities and interfaces. Nucleic Acids Res 40(15):e115, 2012.
16. Kelly KJ, Williams WW Jr, Colvin RB, Meehan SM, Springer TA, Gutierrez-Ramos JC, Bonventre JV: Intercellular adhesion molecule-1-deficient mice are protected against ischemic renal injury. J Clin Invest 97(4):1056-1063, 1996.
17. Brown AC, Blank U, Adams DC, Karolak MJ, Fetting JL, Hill BL, Oxburgh L: Isolation and culture of cells from the nephrogenic zone of the embryonic mouse kidney. J Vis Exp; 2011;(50):e2555, 2011.
18. Mishra J, Ma Q, Prada A, Mitsnefes M, Zahedi K, Yang J, Barasch J, Devarajan P: Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury. J Am Soc Nephrol 14(10):2534-2543, 2003.
19. Ichimura T, Bonventre JV, Bailly V, Wei H, Hession CA, Cate RL, Sanicola M: Kidney injury molecule-1 (KIM-1), a putative epithelial cell adhesion molecule containing a novel immunoglobulin domain, is up-regulated in renal cells after injury. J Biol Chem 273(7):4135-4142, 1998.
20. Aziz M, Jacob A, Wang P: Revisiting caspases in sepsis. Cell Death Dis 5:e1526, 2014.
21. Kim HJ, Lee JS, Kim JD, Cha HJ, Kim A, Lee SK, Lee SC, Kwon BS, Mittler RS, Cho HR, et al.: Reverse signaling through the costimulatory ligand CD137L in epithelial cells is essential for natural killer cell-mediated acute tissue inflammation. Proc Natl Acad Sci USA 109(1): E13-22, 2012.
22. Devarajan P: Neutrophil gelatinase-associated lipocalin (NGAL): a new marker of kidney disease. Scand J Clin Lab Invest Suppl 241:89-94, 2008.
23. Bonventre JV: Kidney injury molecule-1 (KIM-1): a urinary biomarker and much more. Nephrol Dial Transplant 24(11):3265-3268, 2009.
24. Sprenkle P, Russo P: Molecular markers for ischemia, do we have something better then creatinine and glomerular filtration rate? Arch Esp Urol 66(1):99-114, 2013.
25. Du C, Wang S, Diao H, Guan Q, Zhong R, Jevnikar AM: Increasing resistance of tubular epithelial cells to apoptosis by shRNA therapy ameli-orates renal ischemia-reperfusion injury. Am J Transplant 6(10):2256-2267, 2006.
26. Arai S, Kitada K, Yamazaki T, Takai R, Zhang X, Tsugawa Y, Sugisawa R, Matsumoto A, Mori M, Yoshihara Y, et al.: Apoptosis inhibitor of macrophage protein enhances intraluminal debris clearance and ameliorates acute kidney injury in mice. Nat Med 22(2):183-193, 2016.
27. Idrovo JP, Yang WL, Matsuda A, Nicastro J, Coppa GF, Wang P: Post-treatment with the combination of 5-aminoimidazole-4-carboxyamide ribonucleoside and carnitine improves renal function after ischemia/reperfusion injury. Shock 37(1):39-46, 2012.
28. Hirano Y, Aziz M, Yang WL, Ochani M, Wang P: Neutralization of osteopontin ameliorates acute lung injury induced by intestinal ischemia-reperfusion. Shock 46(4):431-438, 2016.
29. Lund SA, Giachelli CM, Scatena M: The role of osteopontin in inflammatory processes. J Cell Commun Signal 3(3-4):311-322, 2009.
30. Weber GF, Zawaideh S, Hikita S, Kumar VA, Cantor H, Ashkar S: Phosphoryl-ation-dependent interaction of osteopontin with its receptors regulates macro-phage migration and activation. J Leukoc Biol 72(4):752-761, 2002.
31. Hirano Y, Aziz M, Yang WL, Wang Z, Zhou M, Ochani M, Khader A, Wang P: Neutralization of osteopontin attenuates neutrophil migration in sepsis-induced acute lung injury. Crit Care 19:53, 2015.
32. Bon D, Chatauret N, Giraud S, Thuillier R, Favreau F, Hauet T: New strategies to optimize kidney recovery and preservation in transplantation. Nat Rev Nephrol 8(6):339-347, 2012.
33. Zhang ZX, Huang X, Jiang J, Lau A, Yin Z, Liu W, Haig A, Jevnikar AM: Natural killer cells mediate long-term kidney allograft injury. Transplantation 99(5):916-924, 2015.